Loading…
Rekvina Labs (BSE 526075)₹67.06+9.88%Pharmaceuticals
Rekvina Labs is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a ROCE of −333.3% against a peer median of 11.5%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mercury Laboratories | 88 | 21.2 | 12.1 | 9.1 | 0.14 | 0.5 | 76 | 5 | −12.0 | −69.8 | vs BSE 526075 |
| Amwill Health Care | 87 | 7.6 | 21.1 | 15.4 | 0.00 | 1.2 | 43 | 11 | 41.1 | 100.0 | vs BSE 526075 |
| Jfl Life Sciences | 85 | 13.0 | 18.0 | 15.0 | 0.47 | 0.0 | 131 | 6 | −4.2 | 48.6 | vs BSE 526075 |
| Denis Chem Lab | 83 | 10.0 | 14.0 | 9.6 | 0.05 | 2.5 | 182 | 8 | 13.1 | −43.1 | vs BSE 526075 |
| Vilin Bio Med | 83 | 43.3 | 10.8 | 7.5 | 0.01 | 0.0 | 42 | 2 | 215.6 | 1,866.7 | vs BSE 526075 |
| Rekvina Labs | 81 | — | −333.3 | — | — | 0.0 | 1 | −0 | — | — | — |
| Samrat Pharmachem | 80 | — | −3.0 | −4.8 | 0.16 | 0.4 | 289 | −3 | 0.7 | — | vs BSE 526075 |
| Shelter Pharma | 76 | 8.3 | 20.4 | 15.1 | 0.01 | 0.8 | 73 | 9 | 49.8 | 22.2 | vs BSE 526075 |
| Source Natural Foods & Herbal Supplements | 75 | 22.0 | — | — | — | 0.0 | 71 | 3 | 76.3 | 7.8 | vs BSE 526075 |
| Vineet Laboratories | 73 | — | −28.0 | −89.5 | 2.99 | 0.0 | 75 | −20 | −13.5 | — | vs BSE 526075 |
| Sunil Healthcare | 72 | 20.0 | 6.5 | 6.0 | 0.80 | 0.0 | 87 | 4 | −16.2 | −50.0 | vs BSE 526075 |
| Peer median | 81 | 16.5 | 11.5 | 9.1 | 0.14 | 0.0 | 75 | 4 | 6.9 | 15.0 |
Listed companies closest to Rekvina Labs in Pharmaceuticals include Mercury Laboratories, Amwill Health Care, Jfl Life Sciences, Denis Chem Lab, Vilin Bio Med, Samrat Pharmachem, Shelter Pharma, Source Natural Foods & Herbal Supplements.
Mercury Laboratories, with a market cap of ₹88.12 Cr.
Rekvina Labs' return on capital employed is −333.3%, below the peer median of 11.5%.